Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosis

INTRODUCTION: Myeloma bone disease (MBD) is the result of the increased activity of osteoclasts (OCs), which is not accompanied by a comparable increase of osteoblast (OB) function, thus leading to enhanced bone resorption. Osteoblasts can also regulate osteoclast activity through expression of cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jinxiang, Wang, Panjun, Zhang, Xiaohui, Ju, Suguang, Li, Jie, Li, Binzhou, Yu, Sun, Zhang, Jianhua, Zhang, Xueguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2010
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284062/
https://www.ncbi.nlm.nih.gov/pubmed/22371791
http://dx.doi.org/10.5114/aoms.2010.14459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284062/
https://www.ncbi.nlm.nih.gov/pubmed/22371791
http://dx.doi.org/10.5114/aoms.2010.14459

Ejemplares similares